Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Cardiología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
OBSERVATIONAL
Inicio: 7 de nov de 2011
ID: NCT01468701
Terminado
Fase 2
ClinicalTrials.gov
Randomised, Double-blind, Placebo-controlled and Parallel Group Trial to Investigate the Effects of Two Doses (Up-titration to a Fixed Dose Regimen) of Oral BI 685509 on Portal Hypertension After 24 Weeks Treatment in Patients With Clinically Significant Portal Hypertension (CSPH) in Compensated Cirrhosis
INTERVENTIONAL
Inicio: 27 de abr de 2022
ID: NCT05161481
Activo, no recluta
Fase 3
ClinicalTrials.gov
The Cardiovascular Safety and Efficacy of Cagrilintide 2.4 mg s.c. in Combination With Semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) Once-weekly in Participants With Established Cardiovascular Disease
INTERVENTIONAL
Inicio: 1 de mar de 2023
ID: NCT05669755
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
INTERVENTIONAL
Inicio: 31 de dic de 2006
ID: NCT00412984
Completado
Fase 3
ClinicalTrials.gov
Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin (SATURN)
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00620542
Completado
ClinicalTrials.gov
Cryo Global Registry, a Part of the Medtronic Cardiac Ablation Post-Market Study Platform
OBSERVATIONAL
Inicio: 2 de may de 2016
ID: NCT02752737
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Subjects With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de jun de 2007
ID: NCT00696241
Completado
ClinicalTrials.gov
Multicenter Observational Cohort Study to Evaluate Cerebral AneurysmFlow Results in Occlusion
OBSERVATIONAL
Inicio: 4 de oct de 2018
ID: NCT03663257
Activo, no recluta
ClinicalTrials.gov
Preventing Ischemic Heart Disease With mHealth, Electronic Decision Support, and Community Health Workers (PRIMECare Trial)
INTERVENTIONAL
Inicio: 14 de oct de 2022
ID: NCT05511701
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Multi-centric, Placebo-controlled, Participant and Investigator-blinded Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Adult Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.
INTERVENTIONAL
Inicio: 3 de mar de 2023
ID: NCT05524051
Completado
Fase 3
ClinicalTrials.gov
Effect of Semaglutide 2.4 mg Once-weekly on Function and Symptoms in Subjects With Obesity-related Heart Failure With Preserved Ejection Fraction, and Type 2 Diabetes
INTERVENTIONAL
Inicio: 15 de jun de 2021
ID: NCT04916470
Completado
Fase 2
ClinicalTrials.gov
A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
INTERVENTIONAL
Inicio: 1 de nov de 2009
ID: NCT00887588
Desconocido
ClinicalTrials.gov
Association of Symptoms, Clinical and Biochemical Characteristics in Post COVID-19 Syndrome: a Case-control Study
OBSERVATIONAL
Inicio: 16 de feb de 2023
ID: NCT05735782
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Controlled, Open-Label, Multi-Centre, Parallel-Group Study To Assess All-Cause Mortality And Cardiovascular Morbidity In Patients With Chronic Kidney Disease On Dialysis And Those Not On Renal Replacement Therapy Under Treatment With MIRCERA® Or Reference ESAs.
INTERVENTIONAL
Inicio: 12 de dic de 2008
ID: NCT00773513
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2a Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-5475 in Adults With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
INTERVENTIONAL
Inicio: 16 de mar de 2023
ID: NCT05612035
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
INTERVENTIONAL
Inicio: 8 de may de 2018
ID: NCT03496623
Completado
Fase 3
ClinicalTrials.gov
An Eight-week Double-blind, Multi-center, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal
INTERVENTIONAL
Inicio: 1 de may de 2008
ID: NCT00706134
Completado
Fase 2
ClinicalTrials.gov
A Multicenter Open-Label Single-Arm Phase II Study Evaluating the Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel in Patients With Metastatic, Recurrent or Persistent Cervical Cancer
INTERVENTIONAL
Inicio: 28 de jul de 2015
ID: NCT02467907
Completado
ClinicalTrials.gov
Healthy Habits Program for High Cardiovascular Risk Patients: Randomized Controlled Clinical Trial. Effectiveness of a Program Using Cognitive Behavioral Therapy to Improve Healthy Habits in a Population With Cardiovascular Disease.
INTERVENTIONAL
Inicio: 1 de jun de 2013
ID: NCT01861977
Completado
Fase 3
ClinicalTrials.gov
A 24-month, Multi-center, Open-label, Randomized, Controlled Trial to Investigate Efficacy, Safety and Evolution of Cardiovascular Parameters in de Novo Renal Transplant Recipients After Early Calcineurin Inhibitor to Everolimus Conversion
INTERVENTIONAL
Inicio: 9 de ago de 2010
ID: NCT01114529
Anterior
1
...
31
32
33
...
434
Siguiente
Filtros